Technical Analysis for DYN - Dyne Therapeutics, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Death Cross | Bearish | 0.73% | |
| Crossed Above 20 DMA | Bullish | 0.73% | |
| Calm After Storm | Range Contraction | 0.73% | |
| Multiple of Ten Bearish | Other | 0.73% | |
| Up 3 Days in a Row | Strength | 0.73% | |
| Calm After Storm | Range Contraction | 1.79% | |
| NR7 | Range Contraction | 1.79% | |
| Calm After Storm | Range Contraction | 2.97% | |
| 20 DMA Resistance | Bearish | 6.41% | |
| Multiple of Ten Bearish | Other | 6.41% |
| Alert | Time |
|---|---|
| 10 DMA Support | about 3 hours ago |
| 20 DMA Support | about 4 hours ago |
| Down 2 % | about 4 hours ago |
| Down 1% | about 4 hours ago |
| Rose Above Previous Day's High | about 4 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/04/2024
Dyne Therapeutics is building a leading muscle disease company focused on advancing innovative life-transforming therapeutics for patients with genetically driven diseases. The Company utilizes its proprietary FORCE™ platform to overcome the current limitations of muscle tissue delivery with modern oligonucleotide therapeutic candidates. Dyne is developing a broad portfolio of therapeutics for muscle diseases, including lead programs in myotonic dystrophy type 1 (DM1), Duchenne muscular dystrophy (DMD) and facioscapulohumeral muscular dystrophy (FSHD).
Sector: Healthcare
Industry: Biotechnology
Keywords: Disease Medical Genetics Dystrophy Muscular Dystrophy Duchenne Muscular Dystrophy Oligonucleotide Duchenne Genetic Genealogy Myotonic Dystrophy Dystrophin Facioscapulohumeral Muscular Dystrophy Muscle Disease Muscle Diseases
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Disease Medical Genetics Dystrophy Muscular Dystrophy Duchenne Muscular Dystrophy Oligonucleotide Duchenne Genetic Genealogy Myotonic Dystrophy Dystrophin Facioscapulohumeral Muscular Dystrophy Muscle Disease Muscle Diseases
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 47.45 |
| 52 Week Low | 10.12 |
| Average Volume | 1,062,687 |
| 200-Day Moving Average | 32.32 |
| 50-Day Moving Average | 32.31 |
| 20-Day Moving Average | 29.69 |
| 10-Day Moving Average | 29.71 |
| Average True Range | 2.14 |
| RSI (14) | 47.37 |
| ADX | 24.05 |
| +DI | 22.16 |
| -DI | 19.30 |
| Chandelier Exit (Long, 3 ATRs) | 29.26 |
| Chandelier Exit (Short, 3 ATRs) | 33.46 |
| Upper Bollinger Bands | 32.32 |
| Lower Bollinger Band | 27.07 |
| Percent B (%b) | 0.56 |
| BandWidth | 17.71 |
| MACD Line | -0.83 |
| MACD Signal Line | -1.06 |
| MACD Histogram | 0.2318 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 32.39 | ||||
| Resistance 3 (R3) | 32.22 | 31.25 | 31.99 | ||
| Resistance 2 (R2) | 31.25 | 30.64 | 31.34 | 31.86 | |
| Resistance 1 (R1) | 30.62 | 30.26 | 30.94 | 30.79 | 31.72 |
| Pivot Point | 29.65 | 29.65 | 29.81 | 29.74 | 29.65 |
| Support 1 (S1) | 29.02 | 29.04 | 29.34 | 29.19 | 28.26 |
| Support 2 (S2) | 28.05 | 28.66 | 28.14 | 28.12 | |
| Support 3 (S3) | 27.42 | 28.05 | 27.99 | ||
| Support 4 (S4) | 27.59 |
